StockData
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$15.87−0.15 (-0.94%)

Close on Nov 18, 2026Market cap $2.96BP/E –Yield –

Dyne Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Dyne Therapeutics's shares outstanding was 52M at Jun 30, 2022. For fiscal 2021 it was 51M, up 253.5% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2021Dec 31, 202151M+253.5%
FY2020Dec 31, 202014M+489.3%
FY2019Dec 31, 20192M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 202252M+0.9%
Q1 FY2022Mar 31, 202252M+4.3%
Q4 FY2021Dec 31, 202152M+644.9%
Q3 FY2021Sep 30, 202151M+1793.4%
Q2 FY2021Jun 30, 202151M+484.9%
Q1 FY2021Mar 31, 202149M+1826.2%
Q3 FY2020Sep 30, 20207M+177.7%
Q2 FY2020Jun 30, 20203M–
Q1 FY2020Mar 31, 20209M–
Q4 FY2019Dec 31, 20193M–
Q3 FY2019Sep 30, 20192M–

More Dyne Therapeutics figures

See a number that looks wrong?